Literature DB >> 27822150

Evaluation of resources for analyzing drug interactions.

Risha I Patel, Robert D Beckett.   

Abstract

OBJECTIVE: The research sought to evaluate seven drug information resources, specifically designed for analyzing drug interactions for scope, completeness, and ease of use, and determine the consistency of content among the seven resources.
METHODS: A cross-sectional study was conducted where 100 drug-drug and drug-dietary supplement interactions were analyzed using 7 drug information resources: Lexicomp Interactions module, Micromedex Drug Interactions, Clinical Pharmacology Drug Interaction Report, Facts & Comparisons eAnswers, Stockley's Drug Interactions (10th edition), Drug Interactions Analysis and Management (2014), and Drug Interaction Facts (2015). The interaction sample was developed based on published resources and peer input. Two independent reviewers gathered data for each interaction from each of the 7 resources using a common form.
RESULTS: Eighty-two drug-drug and 18 drug-dietary supplement interactions were analyzed. Scope scores were higher for Lexicomp Interactions (97.0%), Clinical Pharmacology Drug Interaction Report (97.0%), and Micromedex Drug Interactions (93.0%) compared to all other resources (p<0.05 for each comparison). Overall completeness scores were higher for Micromedex Drug Interactions (median 5, interquartile range [IQR] 4 to 5) compared to all other resources (p<0.01 for each comparison) and were higher for Lexicomp Interactions (median 4, IQR 4 to 5), Facts & Comparisons eAnswers (median 4, IQR 4 to 5), and Drug Interaction Facts (4, IQR 4 to 5) compared to all other resources, except Micromedex (p<0.05 for each comparison). Ease of use, in terms of time to locate information and time to gather information, was similar among resources. Consistency score was higher for Micromedex (69.9%) compared to all other resources (p<0.05 for each comparison).
CONCLUSIONS: Clinical Pharmacology Drug Interaction Report, Lexicomp Interactions, and Micromedex Drug Interactions scored highest in scope. Micromedex Drug Interactions and Lexicomp Interactions scored highest in completeness. Consistency scores were overall low, but Micromedex Drug Interactions was the highest.

Keywords:  Drug-Dietary Supplement Interactions; Drug-Drug Interactions; Pharmacy

Mesh:

Year:  2016        PMID: 27822150      PMCID: PMC5079490          DOI: 10.3163/1536-5050.104.4.007

Source DB:  PubMed          Journal:  J Med Libr Assoc        ISSN: 1536-5050


  5 in total

1.  Clinically important drug-drug interactions and how to manage them.

Authors:  Linda Bryant; Tana Fishman
Journal:  J Prim Health Care       Date:  2009-06

Review 2.  Clinical approach to adverse events and interactions related to herbal and dietary supplements.

Authors:  Christine A Haller
Journal:  Clin Toxicol (Phila)       Date:  2006       Impact factor: 4.467

3.  Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions.

Authors:  Daniel C Malone; Jacob Abarca; Philip D Hansten; Amy J Grizzle; Edward P Armstrong; Robin C Van Bergen; Babette S Duncan-Edgar; Steven L Solomon; Richard B Lipton
Journal:  J Am Pharm Assoc (2003)       Date:  2004 Mar-Apr

4.  Ability of online drug databases to assist in clinical decision-making with infectious disease therapies.

Authors:  Hyla H Polen; Antonia Zapantis; Kevin A Clauson; Jennifer Jebrock; Mark Paris
Journal:  BMC Infect Dis       Date:  2008-11-06       Impact factor: 3.090

5.  Clinical decision support tools: analysis of online drug information databases.

Authors:  Kevin A Clauson; Wallace A Marsh; Hyla H Polen; Matthew J Seamon; Blanca I Ortiz
Journal:  BMC Med Inform Decis Mak       Date:  2007-03-08       Impact factor: 2.796

  5 in total
  19 in total

Review 1.  Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia.

Authors:  Ramon Cacabelos
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

2.  Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study.

Authors:  Qasim Khan; Mohammad Ismail; Iqbal Haider; Fahadullah Khan
Journal:  Int J Clin Pharm       Date:  2017-09-12

Review 3.  A Scoping Review of the Evidence Behind Cytochrome P450 2D6 Isoenzyme Inhibitor Classifications.

Authors:  Emily J Cicali; D Max Smith; Benjamin Q Duong; Lukas G Kovar; Larisa H Cavallari; Julie A Johnson
Journal:  Clin Pharmacol Ther       Date:  2020-02-13       Impact factor: 6.875

Review 4.  Polypharmacy and Cardiovascular Diseases: Consideration for Older Adults and Women.

Authors:  Shreya Patel; Manish Kumar; Craig J Beavers; Saad Karamat; Fawaz Alenezi
Journal:  Curr Atheroscler Rep       Date:  2022-07-21       Impact factor: 5.967

5.  Potential adverse drug events and its predictors among hospitalized patients at medical center in Ethiopia: a prospective observational study.

Authors:  Tamiru Sahilu; Mestawet Getachew; Tsegaye Melaku; Tadesse Sheleme; Duresa Abu; Tesfu Zewdu
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

6.  The Prevalence of the Potential Drug-Drug Interactions Involving Anticancer Drugs in China: A Retrospective Study.

Authors:  Weilan Wang; Bingkun Xiao; Ziqi Liu; Dongxiao Wang; Man Zhu
Journal:  Iran J Public Health       Date:  2019-03       Impact factor: 1.429

7.  Comparison of potential drug-drug interactions with metabolic syndrome medications detected by two databases.

Authors:  Bovornpat Suriyapakorn; Pun Chairat; Suwanan Boonyoprakarn; Pimonwan Rojanarattanangkul; Wassana Pisetcheep; Natthaphon Hunsakunachai; Pornpun Vivithanaporn; Supakit Wongwiwatthananukit; Phisit Khemawoot
Journal:  PLoS One       Date:  2019-11-14       Impact factor: 3.240

8.  Performance Assessment of Software to Detect and Assist Prescribers with Antimicrobial Drug Interactions: Are all of them Created Equal?

Authors:  Elena Morte-Romea; Pilar Luque-Gómez; Mercedes Arenere-Mendoza; Jose Luis Sierra-Monzón; Ana Camón Pueyo; Galadriel Pellejero Sagastizabal; Guillermo Verdejo Muñoz; David Sánchez Fabra; José Ramón Paño-Pardo
Journal:  Antibiotics (Basel)       Date:  2020-01-04

9.  Annotation and detection of drug effects in text for pharmacovigilance.

Authors:  Paul Thompson; Sophia Daikou; Kenju Ueno; Riza Batista-Navarro; Jun'ichi Tsujii; Sophia Ananiadou
Journal:  J Cheminform       Date:  2018-08-13       Impact factor: 5.514

10.  Evaluation of drug information resources for drug-ethanol and drug-tobacco interactions.

Authors:  Robert D Beckett; Curtis D Stump; Megan A Dyer
Journal:  J Med Libr Assoc       Date:  2019-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.